TNFA

TNFA

USD

TNF Pharmaceuticals Inc. Common Stock

$5.200-0.430 (-7.638%)

Prix en Temps Réel

Technologie
Matériel informatique
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$5.630

Haut

$8.900

Bas

$4.200

Volume

0.52M

Fondamentaux de l'Entreprise

Capitalisation Boursière

9.6M

Industrie

Matériel informatique

Pays

United States

Statistiques de Trading

Volume Moyen

1.82M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $3.24Actuel $5.200Haut $195

Actualités Connexes

BusinessWire

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"

Licensed technology positions Company at forefront of new quantum-class computing paradigm

Voir plus
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"
BusinessWire

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing

New trading symbol QCLS effective Thursday, September 25, 2025 Licensed technology positions Company at forefront of new quantum-class computing paradigm TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("Q/C" or the

Voir plus
TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing
BusinessWire

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals Inc. (NASDAQ:TNFA), ("TNF" or the "Company") today announced that it received written notice from the Nasdaq Stock Market on September 16, 2025, confirming that the Company has regained compliance

Voir plus
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
BusinessWire

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Management to present on Wednesday, September 10, 2025, at 8:00 a.m. ET TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company") today announced its participation in the H.C. Wainwright & Co. 27th Annual

Voir plus
TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference